Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
ACS Publications
Abstract
A library of potent and highly A3AR selective pyrimidine-based compounds was designed to explore non-orthosteric interactions within this receptor. Starting from a prototypical orthosteric A3AR antagonist (ISVY130), the structure-based design explored functionalized residues at the exocyclic amide L1 region and aimed to provide additional interactions outside the A3AR orthosteric site. The novel ligands were assembled through an efficient and succinct synthetic approach, resulting in compounds that retain the A3AR potent and selective profile while improving the solubility of the original scaffold. The experimentally demonstrated tolerability of the L1 region to structural functionalization was further assessed by molecular dynamics simulations, giving hints of the non-orthosteric interactions explored by these series. The results pave the way to explore newly functionalized A3AR ligands, including covalent drugs and molecular probes for diagnostic and delivery purposes
Description
Bibliographic citation
ACS Med. Chem. Lett. 2022, 13, 2, 243–249
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1021/acsmedchemlett.1c00598Sponsors
This work has received financial support from the Consellería de Cultura, Educación e Ordenación Universitaria [Galician Government (grant: ED431B 2020/43)], the Xunta de Galicia (Centro singular de investigación de Galicia accreditation 2019-2022, ED431G 2019/03), the European Union (European Regional Development Fund - ERDF), the Swedish Research Council (grant: 521-2014-2118), and the Swedish strategic research program eSSENCE. The computational studies were conducted with the resources available from the Swedish National Infrastructure for Computing (SNIC). The project was carried out within the framework of the collaborative EU COST action ERNEST (CA18133)
Rights
© 2022 The Authors. Published by American Chemical Society. This work is under a CC Attribution 4.0 International (CC BY 4.0)
Atribución 4.0 Internacional
Atribución 4.0 Internacional








